Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Visa sponsorship

  • United States · Filed H-1B visas in the last two years

Visa details by country

Overview

About Us Home About Elephas About Us We're driven to improve the lives of those affected by cancer. Cancer remains one of the world's greatest health challenges, and the number of people affected is expected to rise dramatically in the decades ahead.

News

Press release PRNewswire 3 months ago
ELEPHAS ANNOUNCES COMMERCIAL PARTNERSHIP WITH INVITROCUE TO EXPAND PERSONALIZED ONCOLOGY IN SOUTHEAST ASIA
/PRNewswire/ -- Elephas Biosciences Corporation, a private company that has developed an innovative live tissue platform for immunotherapy response prediction,...
Read more
Report
News YahooFinance 6 months ago
ELEPHAS BIOSCIENCES AND MITHRL PAIR REAL-TIME TUMOR PROFILING WITH AGENTIC AI TO UNLOCK NEW IMMUNOTHERAPY RESPONSE INSIGHTS
Elephas Biosciences Corporation (Elephas), a private company that has developed the elive ex vivo tumor profiling platform, announced a scientific collaboration with Mithrl, an AI company focused on accelerating research through its Scientific Decision En
Read more
Report
News YahooFinance 8 months ago
ELEPHAS BIOSCIENCES ANNOUNCES NEW RESEARCH PARTNERSHIP WITH THE UNIVERSITY OF LOUISVILLE TO STUDY ADVANCED STAGE SOLID CANCER TUMORS IN COLORECTAL, LIVER AND PANCREATIC CANCERS
Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today a new research partnership with the University of Louisville that will evaluate the i
Read more
Report
Press release PRNewswire 10 months ago
ELEPHAS BIOSCIENCES APPOINTS DR. JOSH ROUTH TO LEAD ELEPHAS LABORATORIES
/PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response...
Read more
Report
News Pulse 2.0 11 months ago
Elephas Biosciences: $40 Million Series B-2 Raised To Advance Commercialization Of Live Tumor Profiling Platform
Elephas Biosciences has secured $40 million in Series B-2 financing to support the launch and commercialization of its Elephas Live Platform, a laboratory-developed test expected to be introduced in 2026. The company, based in Madison, Wisconsin, has deve
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Elephas Biosciences over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
1
Stack modernity
85/100
Languages
Python
Practices & domains
Machine Learning
Sign in to see how your skills match this stack Sign In

People

Terrence Brady
Executive Officer
Maneesh Arora
Executive Officer, Director
Jonathan Oliner
Executive Officer
Michelle Arora
Director
Andrea Jackson
Director
Steven Galson
Director
Paul Berns
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~10 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
100% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Madison
Madison United States
HQ
Follow us on
2 open roles 1 posted in 90 days 50% engineering
hires for Data Science, Early Careers
• 1 Erdman Pl, Suite 100, Madison, WI 53717, United States
seen since Jun 2026 company site, job postings

Jobs

≈ $106k – $201k per year (Estimated) • Equity • In office • Full-Time • 1+ year exp • Master's Degree • Madison
Python
Machine Learning
Apply